Psoriatic arthritis (PsA) is associated with a higher burden of cardiometabolic disorders,
such as hypertension, dyslipidemia, diabetes, obesity, and cardiovascular disease (CVD) …

Background and objective Cardiovascular diseases (CVD) are the leading causes of death
in chronic inflammatory rheumatic diseases and are not solely explained by the increased …

Aims: Psoriasis is an immune-mediated dermatosis with cardio-metabolic comorbidities. The
aim of this study was to assess insulin-resistance, lipid abnormalities, and cardiovascular …

Background: The interest in phenolic compounds present in foods of vegetable origin has
shown a notable increase in recent decades. This interest is due to the growing number of …

Background. IL‐33 belongs to the IL‐1 family, playing a role in several biologic processes as
well as in the pathogenesis of different diseases, including skin pathologies. It acts as an …

Psoriasis is a chronic immune‐mediated disease characterized by inflammation of skin
(psoriasis) or joints (psoriatic arthritis) or both, resulting from a dysregulation in particular of …

Objective Studies on pregnancy outcomes in psoriatic arthritis (PsA) are scarce and typically
of small size. Available studies have reported conflicting results. The aim of this study was to …

Purpose Patients affected by heart failure with reduced ejection fraction (HFrEF) receive
clinical and functional beneficial effects from treatment with sacubitril/valsartan. However …

Psoriasis (Pso) is a chronic inflammatory immune-mediated skin disease associated with
several comorbidities. Despite the growing number of studies providing evidence for the link …

The pathological mechanism of psoriasis and dyslipidemia comorbidity is unclear, and there
are few reports on therapy. By establishing an animal model of ApoE−/− mice induced by …